Sex differences in clinical presentation and response in panic disorder: Pooled data from sertraline treatment studies

Archives of Women's Mental Health

Volumn 9, Issue 3, 2006, Pages 151-157

  Clayton, A H ^a,d   Stewart, R S ^b   Fayyad, R ^c   Clary, C M ^c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c PFIZER INC   (United States)

^d UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Inhibitors; Panic disorder; Serotonin reuptake; Sertraline; Sex

Indexed keywords

ESTROGEN; ORAL CONTRACEPTIVE AGENT; PLACEBO; PROGESTERONE; SERTRALINE;

ADULT; AGORAPHOBIA; ALCOHOLISM; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; FATIGUE; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; NAUSEA; ONSET AGE; PANIC; PATIENT COMPLIANCE; PRIORITY JOURNAL; SEDATION; SEX DIFFERENCE; SIDE EFFECT; SUBSTANCE ABUSE; UNSPECIFIED SIDE EFFECT; XEROSTOMIA;

ADULT; AGORAPHOBIA; ANALYSIS OF VARIANCE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PANIC DISORDER; RANDOMIZED CONTROLLED TRIALS; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SEX FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; UNITED STATES;

EID: 33745787953     PISSN: 14341816     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00737-005-0111-y     Document Type: Article

References (34)

1. J Amsterdam F Garcia-Espana J Fawcett F Quitkin F Reimherr J Rosenbaum C Beasley 1999 Fluoxetine efficacy in menopausal women with and without estrogen replacement J Affect Disord 55 11 17
2. L Andrade WW Eaton HD Chilcoat 1996 Lifetime co-morbidity of panic attacks and major depression in a population-based study: age of onset Psychol Med 26 991 996
3. JC Ballenger DE Wheadon M Steiner W Bushnell I Gergel 1998 Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder Am J Psychiatry 155 36 42
4. G Barzega G Maina S Venturello F Bogetto 2001 Gender-related differences in the onset of panic disorder Acta Psychiatr Scand 103 189 195
5. M Battaglia L Bernardeschi E Politi S Bertella L Bellodi 1995 Comorbidity of panic and somatization disorder: a genetic-epidemiological approach Compr Psychiatry 36 411 420
6. JL Bibb DL Chambless 1986 Alcohol use and abuse among diagnosed agoraphobics Behav Res Ther 24 49 58
7. BJ Cox RP Swinson ID Shulman K Kuch JT Reichman 1993 Gender effects and alcohol use in panic disorder with agoraphobia Behav Res Ther 31 413 416
8. CL Dick RC Bland SC Newman 1994 Epidemiology of psychiatric disorders in Edmonton. Panic disorder Acta Psychiatr Scand [Suppl] 376 45 53
9. J Endicott J Nee W Harrison R Blumenthal 1993 Quality of life, enjoyment and satisfaction questionnaire: a new measure Psychopharmacol Bull 29 321 326
10. Guy W (1976) ECDEU Assessment manual for psychopharmacology, revised. Rockville MD: DHEW Publication No. (ABM), pp 76-338.
11. RJ Hafner 1983 Behaviour therapy for agoraphobic men Behav Res Ther 21 51 56
12. M Hamilton 1959 The assessment of anxiety status by rating Br J Med Psychol 32 50 55
13. M Hollifield W Katon B Skipper T Chapman JC Ballenger S Mannuzza AJ Fyer 1997 Panic disorder and quality of life: variables predictive of functional impairment Am J Psychiatry 154 766 772
14. MR Johnson RB Lydiard 1998 Comorbidity of major depression and panic disorder J Clin Psychol 54 201 210
15. RC Kessler CG Davis KS Kendler 1997 Childhood adversity and adult psychiatric disorder in the US National Comorbidity Survey Psychol Med 27 1101 1119
16. RC Kessler KA [tmp] McGonagle S Zhao CB Nelson M Hughes S Eshleman H Wittchen K Kendler 1994 Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey Arch Gen Psychiatry 51 8 19
17. Y Lecrubier A Bakker G Dunbar R Judge 1997 A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators Acta Psychiatr Scand 95 145 152
18. PM Lewinsohn IH Gotlib M Lewinsohn JR Seeley NB Allen 1998 Gender differences in anxiety disorders and anxiety symptoms in adolescents J Abnorm Psychol 107 109 117
19. PD Londborg R Wolkow WT Smith E DuBoff D England J Ferguson M Rosenthal C Weise 1998 Sertraline in the treatment of panic disorder: A multisite, double-blind, placebo-controlled fixed dose investigation Br J Psychiatry 173 54 60
20. W Maier R Buller 1988 One year follow-up of panic disorder: outcome and prognostic factors Eur Arch Psychiatry Neurol Sci 238 105 109
21. JR Marshall 1996 Comorbidity and its effects on panic disorder Bull Menninger Clin 60 2 [Suppl] A A39 A53
22. DM [tmp] McNair M Lorr LF Droppleman 1971 Manual for the Profile of Mood States Educational & Industrial Testing Service San Diego
23. R Noyes J Clancey PR Hoenk DJ Slymen 1980 The prognosis of anxiety neurosis Arch Gen Psychiatry 37 173 178
24. RJ Noyes J Reich J Christiansen M Suelzer B Pfohl WA Coryell 1990 Outcome of panic disorder: relationship to diagnostic subtypes and comorbidity Arch Gen Psychiatry 47 809 818
25. RB Pohl RM Wolkow CM Clary 1998 Sertraline in the treatment of panic disorder: a double-blind multicenter trial Am J Psychiatry 155 1189 1195
26. MH Pollack MW Otto J Worthington G Manfro R Wolkow 1998 Sertraline in the treatment of panic disorder. A flexible-dose multicenter trial Arch Gen Psychiatry 55 11 1010 1016
27. MH Pollack MH Rapaport CM Clary J Mardekian R Wolkow 2000 Sertraline treatment of panic disorder: reponse in patients at risk for poor outcome J Clin Psychiatry 61 922 927
28. LS Schneider GW Small SH Hamilton A Bystritsky CB Nemeroff BS Meyers 1997 Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial Am J Geriatric Psychiatry 5 97 106
29. MK Shear TA Brown DH Barlow R Money D Sholomskas S Woods J Gorman L Papp 1997 Multicenter collaborative panic disorder severity scale Am J Psychiatry 154 1571 1575
30. JI Sheikh P Londborg 2000 The efficacy of sertraline in panic disorder: combined results from two fixed-dose studies (Eng) Int Clin Psychopharmacol 15 6 335 342
31. V Starcevic A Djordjevic M Latas G Bogojevic 1998 Characteristics of agoraphobia in women and men with panic disorder with agoraphobia Depress Anxiety 8 8 13
32. MB Stein JR Walker G Anderson A Hazen C Ross G Eldridge D Forde 1996 Childhood physical and sexual abuse in patients with anxiety disorders and in a community sample Am J Psychiatry 153 275 277
33. L Turgeon A Marchand G Dupuis 1998 Clinical features in panic disorder with agoraphobia: a comparison of men and women J Anxiety Disord 12 539 553
34. KA Yonkers C Zlotnick J Allsworth M Warshaw T Shea M Keller 1998 Is the course of panic disorder the same in women and men? Am J Psychiatry 155 596 602